Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Viral Hepat. 2016 Feb 3;23(5):366–374. doi: 10.1111/jvh.12507

Table 1.

Factors associated with HCV antibody positivity.

Characteristic No. Screened HCV Prevalence (%) OR (95% CI) Adjusted OR (95% CI)
Age
 Non-Birth Cohort 2246 2.8
 Birth Cohorta 435 29.2 14.5 (10.5–20.1) 17.9 (12.0–26.8)
Sex
 Female 1019 5.0
 Male 1660 8.3 1.7 (1.2–2.4) 2.4 (1.5–3.6)
Race/Ethnicity
Black 2408 6.6
Non-Black 273 11.4 1.8 (1.2–2.7) 1.8 (1.3–2.4)
HIV status
 Negative 2608 6.9
 Positive 73 11.0 1.7 (0.8–3.5) 1.6 (0.6–4.1)
MSM
 No 2509 7.3
 Yes 172 2.9 0.4 (0.2–0.9) 0.3 (0.1–0.8)
Ever IDU
No 2524 2.3
Yes 157 84.1 228.5 (138.4–377.4) N/A
Current IDU
 No 2633 5.8
 Yes 48 77.1 54.9 (27.5–109.8) 76.1 (33.1–174.7)
Non-IDU
 No 2566 5.9
 Yes 115 33.9 8.3 (5.4–12.6) 3.4 (2.0–6.0)
Hazardous alcohol consumptionb
 No 1968 7.9
 Yes 713 4.6 0.6 (0.4–0.8) 0.6 (0.4–1.0)
Insurance status
 No 1419 4.5
 Yes 1262 9.9 2.3 (1.7–3.2) 1.8 (1.2–2.5)
>2 sex partners in past 90 days/anonymous sex
 No 2112 7.2
 Yes 569 6.5 0.9 (0.6–1.3)
Prior STD diagnosis
 No 1521 6.8
 Yes 1160 7.4 1.1 (0.8–1.5)
STD diagnosis on date of HCV diagnosis
 No 2122 7.1
 Yes 559 6.8 1.0 (0.7–1.4)
a

Birth cohort: Individuals born between 1945 and 1965, as defined by the CDC.

b

Hazardous alcohol consumption defined as reported use of ≥4 alcoholic drinks in 1 sitting or risky sex under the influence of alcohol in the preceding 30 days

Ever IDU not included in the multivariable analysis

Abbreviations used in the table:

Current IDU: Current (within past 12 months) injection drug use.

Non-IDU: Non injection drug use within the past 12 months.

HIV: Human Immunodeficiency Virus

MSM: Men who have Sex with Men

STD: Sexually Transmitted Disease

HCV: Hepatitis C Virus